Candel Therapeutics(CADL) - 2024 Q1 - Quarterly Report

i The accompanying notes are an integral part of these condensed consolidated financial statements. | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------------|-------|------------------------------|-------|-------|--------| | Assets | | MARCH 31, 2024 (Unaudited) | | 2023 | | | Current assets: | | | | | | | Cash and cash equivalents | $ | 25,713 | $ | | 35,413 | | Prepaid expenses and other current assets | | 1,423 | | | 1,384 | | Total current assets | | 27,1 ...